Aloxiprin: Difference between revisions

	WikiDoc Resources for Aloxiprin
Articles
Most recent articles on Aloxiprin Most cited articles on Aloxiprin Review articles on Aloxiprin Articles on Aloxiprin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Aloxiprin Images of Aloxiprin Photos of Aloxiprin Podcasts & MP3s on Aloxiprin Videos on Aloxiprin
Evidence Based Medicine
Cochrane Collaboration on Aloxiprin Bandolier on Aloxiprin TRIP on Aloxiprin
Clinical Trials
Ongoing Trials on Aloxiprin at Clinical Trials.gov Trial results on Aloxiprin Clinical Trials on Aloxiprin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Aloxiprin NICE Guidance on Aloxiprin NHS PRODIGY Guidance FDA on Aloxiprin CDC on Aloxiprin
Books
Books on Aloxiprin
News
Aloxiprin in the news Be alerted to news on Aloxiprin News trends on Aloxiprin
Commentary
Blogs on Aloxiprin
Definitions
Definitions of Aloxiprin
Patient Resources / Community
Patient resources on Aloxiprin Discussion groups on Aloxiprin Patient Handouts on Aloxiprin Directions to Hospitals Treating Aloxiprin Risk calculators and risk factors for Aloxiprin
Healthcare Provider Resources
Symptoms of Aloxiprin Causes & Risk Factors for Aloxiprin Diagnostic studies for Aloxiprin Treatment of Aloxiprin
Continuing Medical Education (CME)
CME Programs on Aloxiprin
International
Aloxiprin en Espanol Aloxiprin en Francais
Business
Aloxiprin in the Marketplace Patents on Aloxiprin
Experimental / Informatics
List of terms related to Aloxiprin

Aloxiprin
Clinical data
ATC code	B01AC15 (WHO) ;
Identifiers
	IUPAC name aluminum 2-acetyloxybenzoate hydroxide;
CAS Number	9014-67-9;
PubChem CID	3032790;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C18H15AlO9
Molar mass	402.288 g/mol

VisualWikitext

Latest revision as of 18:05, 27 July 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Aloxiprin (or aluminium acetylsalicylate) is a medical drug used for the treatment of pain and inflammation associated with muscular skeletal and joint disorders.^[1] It is used for its properties as an anti-inflammatory, antipyretic and analgesic drug.^[1] It is a chemical compound of aluminium hydroxide and aspirin.^[2]^[3]

Alternative Names and Combinations

Palaprin Forte.^[4]
Askit- A powder combination of aspirin, aloxiprin and caffeine.^[5]

Contraindications

People with allergies to salicylates.
People with gastrointestinal ulcers.
People with liver or kidney damage.
Pregnant women in the 3rd trimester.
Women who are breastfeeding.
Use with other salicylates.
Use with NSAIDs.

External Links

http://ctd.mdibl.org/detail.go;?type=chem&acc=C010843

References

↑ ^1.0 ^1.1 MIMS. "Aloxiprin". MIMS. Retrieved 16 April 2011.
↑ Encarta. "Aloxiprin". Encarta. Retrieved 16 April 2011.
↑ CUMMINGS AJ, MARTIN BK, WIGGINS LF (1963). "In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid". J. Pharm. Pharmacol. 15: 56–62. PMID 14024235.
↑ Geller J (1968). "A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin')". The British journal of clinical practice. 22 (9): 392–4. PMID 4876729.
↑ Net Doctor UK. "Askit Powders". Treatments for joint, muscle and bone conditions. Retrieved 16 April 2011.

[mimsonline-1] 1.0 ^1.1 MIMS. "Aloxiprin". MIMS. Retrieved 16 April 2011.

[2] Encarta. "Aloxiprin". Encarta. Retrieved 16 April 2011.

[pmid14024235-3] CUMMINGS AJ, MARTIN BK, WIGGINS LF (1963). "In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid". J. Pharm. Pharmacol. 15: 56–62. PMID 14024235.

[pmid4876729-4] Geller J (1968). "A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin')". The British journal of clinical practice. 22 (9): 392–4. PMID 4876729.

[5] Net Doctor UK. "Askit Powders". Treatments for joint, muscle and bone conditions. Retrieved 16 April 2011.

[1]

[2]

[3]

[4]

[5]

@@ Line 24: / Line 24: @@
 | routes_of_administration =
 }}
+__NOTOC__
 {{SI}}
 {{CMG}}
+==Overview==
+'''Aloxiprin''' (or '''aluminium acetylsalicylate''') is a medical drug used for the treatment of pain and inflammation associated with muscular skeletal and joint disorders.<ref name="mimsonline">{{cite web|last=MIMS|title=Aloxiprin|url=http://www.mimsonline.com/USA/drug/info/aloxiprin?type=brief&h=nonsteroidal,anti,inflammatory,drugs,nsaids|work=MIMS|accessdate=16 April 2011}}</ref>
+It is used for its properties as an [[anti-inflammatory]], [[antipyretic]] and [[analgesic]] drug.<ref name="mimsonline" />
+It is a chemical compound of aluminium hydroxide and [[aspirin]].<ref>{{cite web|last=Encarta|title=Aloxiprin|url=http://uk.encarta.msn.com/dictionary_1481579253_1861822000/prevpage.html|work=Encarta|accessdate=16 April 2011}}</ref><ref name="pmid14024235">{{cite journal |author=CUMMINGS AJ, MARTIN BK, WIGGINS LF |title=In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid |journal=J. Pharm. Pharmacol. |volume=15 |issue= |pages=56–62 |year=1963 |pmid=14024235 |doi=}}</ref>
+==Alternative Names and Combinations==
+* Palaprin Forte.<ref name="pmid4876729">{{cite journal |author=Geller J |title=A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin') |journal=The British journal of clinical practice |volume=22 |issue=9 |pages=392–4 |year=1968 |pmid=4876729 |doi=}}</ref>
+*Askit- A powder combination of aspirin, aloxiprin and caffeine.<ref>{{cite web|last=Net Doctor UK|title=Askit Powders|url=http://www.netdoctor.co.uk/medicines/100000180.html|work=Treatments for joint, muscle and bone conditions|accessdate=16 April 2011}}</ref>
-==Overview==
+==Contraindications==
-'''Aloxiprin''' (or '''aluminum acetylsalicylate''') is a platelet aggregation inhibitor. It is derived from [[aspirin]].<ref name="pmid14024235">{{cite journal |author=CUMMINGS AJ, MARTIN BK, WIGGINS LF |title=In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid |journal=J. Pharm. Pharmacol. |volume=15 |issue= |pages=56-62 |year=1963 |pmid=14024235 |doi=}}</ref>
+* People with allergies to salicylates.
+* People with gastrointestinal ulcers.
+* People with liver or kidney damage.
+* Pregnant women in the 3rd trimester.
+* Women who are breastfeeding.
+* Use with other salicylates.
+* Use with NSAIDs.
-It is also known as "Palaprin Forte".<ref name="pmid4876729">{{cite journal |author=Geller J |title=A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin') |journal=The British journal of clinical practice |volume=22 |issue=9 |pages=392-4 |year=1968 |pmid=4876729 |doi=}}</ref>
+==External Links==
+* http://ctd.mdibl.org/detail.go;?type=chem&acc=C010843
 ==References==
-<references/>
+{{reflist|2}}
-==External links==
-* http://ctd.mdibl.org/detail.go;?type=chem&acc=C010843
 {{Antithrombotics}}
+[[Category:Drug]]
-[[Category:Benzoates]]
+[[Category:Cardiovascular Drugs]]
-[[Category:Aluminium compounds]]
+[[Category:Antiplatelet drugs]]
-[[Category:Drugs]]
-{{WikiDoc Help Menu}}
-{{WikiDoc Sources}}

Clinical data

ATC code	B01AC15 (WHO)
Identifiers
IUPAC name aluminum 2-acetyloxybenzoate hydroxide
CAS Number	9014-67-9
PubChem CID	3032790
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₈H₁₅AlO₉
Molar mass	402.288 g/mol